Abstract:The addition of O-linked-beta-N-acetylglucosamine (O-GlcNAc) onto serine and threonine residues of nuclear and cytoplasmic proteins is an abundant and unique post-translational modification that plays a critical role in governing important biological processes. Since its discovery, O-GlcNAcylation has been shown to contribute to numerous cellular processes, including signaling, protein localization and stability, transcription, chromatin remodeling, mitochondrial function, and cell survival. O-GlcNAcylation is a dynamic and reversible post-translational modification that regulates protein function in a site-specific manner, making it an important player in the regulation of diverse biological processes. Dysregulation of O-GlcNAcylation has been implicated in the pathogenesis of various diseases, including cancer, neurodegenerative disorders, and diabetes. To better understand the regulatory roles of O-GlcNAcylation in cellular physiology and disease pathogenesis, O-GlcNAc proteomics strategies and more specialized, more exact research tools are needed to further explore the bio-functional systematization of O-GlcNAcylation. In recent years, the field of chemical biology has developed various tools and methods for analyzing O-GlcNAc glycosylation, including small molecule sugar probes, metabolic labeling reagents, chemoenzymatic techniques, specific antibodies, and lectins. These tools have served as a foundation for the further development of O-GlcNAc glycoproteomic research strategies. O-GlcNAc glycoproteomic strategies, such as high-resolution mass spectrometry-based approaches have been developed to allow for the detection and quantification of O-GlcNAc modifications on specific proteins, enabling site-specific analysis of O-GlcNAc modification patterns. The number of proteins modified by O-GlcNAc is quite extensive, with at least 7000 modification sites identified in human cells. This highlights the importance of O-GlcNAcylation in regulating diverse biological processes. Identification of O-GlcNAcylation sites with specific biological functions is still a remaining problem. Innovative solutions are required to address this challenge in cell models and disease therapy. At the same time, with the aid of high-resolution mass spectrometry, a large number of O-GlcNAc modification sites on proteins have been identified, which has greatly promoted the study of site-specific O-GlcNAc biological functions. This article has reviewed the recent advances in the field of O-GlcNAc research, with the aim of providing a basis for the development of more chemical tools and offering new research ideas and strategies for uncovering the functions of O-GlcNAcylation in disease progression.

N‐Glycosylation‐induced pathologic protein conformations as a tool to guide the selection of biologically active small molecules

N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease

Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

Abstract 2831: Development of Selective GRP94 Inhibitors for the Treatment of Cancer

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

Protein Degradation via CRL4 CRBN Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1.

Development Of Selective Grp94 Inhibitors For The Treatment Of Cancer

Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression

Impact of N-Linked Glycosylation on Therapeutic Proteins

Interaction networks within disease-associated GαS variants characterized by an integrative biophysical approach

Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells

Chemical and Chemoenzymatic Synthesis of Peptide and Protein Therapeutics Conjugated with Human N‐Glycans

Identification and characterization of nanobodies acting as molecular chaperones for glucocerebrosidase through a novel allosteric mechanism

Application of Chemical Biology to Reveal the Function of O-GlcNAcylation in Diseases: Research Tools and Tactics

Regulated N-glycosylation controls chaperone function and receptor trafficking

N-glycosylation as a eukaryotic protective mechanism against protein aggregation

Metabolic Control of Glycosylation Forms for Establishing Glycan-Dependent Protein Interaction Networks

High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease

Dynamic Insights into Hsp90 Inhibitor Binding: Uncovering Intermediate States and Conformational Plasticity